You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,078,058


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,078,058
Title:Corticosteroid-containing pharmaceutical composition
Abstract:A foamable pharmaceutical composition comprising a corticosteroid, a quick-break foaming agent, a propellant and a buffering agent, sufficient to buffer the composition to within the range of pH 3.0 to 6.0 is disclosed. The quick-break foaming agent typically comprises an aliphatic alcohol, water, a fatty alcohol and a surface active agent. Due to the nature of the compositions of the invention, they are especially well-suited for use in the treatment of various skin diseases, and in particular, in the treatment of scalp psoriasis.
Inventor(s): Jones; Julie Irene (Harpenden, GB), Baker; Anthony Richard (West Horsley, GB), Halls; Neil Graham (Glen Waverley, AU), Watmough; Peter (Grimsby, GB), Marriott; Peter (Grimsby, GB)
Assignee: Connetics Australia Pty Ltd (Rowville, AU)
Application Number:10/256,754
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,078,058

Introduction

United States Patent 7,078,058, titled "Foamable Pharmaceutical Compositions and Uses Thereof," is a significant patent in the pharmaceutical industry, particularly in the treatment of scalp psoriasis. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Patent Title and Number

  • Title: Foamable Pharmaceutical Compositions and Uses Thereof
  • Number: 7,078,058
  • Grant Date: October 11, 2006

Inventors and Assignees The patent was invented by several individuals and assigned to Connetics Corporation, a company known for its dermatological treatments[2].

Scope of the Patent

The patent covers foamable pharmaceutical compositions, specifically those containing steroids, designed for treating scalp psoriasis and other skin conditions.

Key Components

  • Foamable Base: The patent describes a foamable base that includes a combination of ingredients such as oils, emollients, and surfactants.
  • Active Ingredients: The primary active ingredient is a steroid, which is incorporated into the foamable base to create a topical treatment.
  • Therapeutic Uses: The compositions are intended for the treatment of scalp psoriasis and other dermatological conditions.

Claims of the Patent

The patent includes several claims that define the scope of the invention.

Independent Claims

  • Claim 1 describes the foamable pharmaceutical composition comprising a steroid and a foamable base.
  • Claim 5 outlines the method of treating scalp psoriasis using the foamable composition.

Dependent Claims

  • These claims further specify the types of steroids, the composition of the foamable base, and the methods of application.

Patent Landscape

Understanding the patent landscape is crucial for assessing the patent's position within the broader intellectual property ecosystem.

Related Patents

  • Patent Family: The patent is part of a family of patents related to foamable pharmaceutical compositions. For example, U.S. Patent 6,126,920 also pertains to steroid-containing foamable compositions[2].
  • Global Dossier: Using the Global Dossier service provided by the USPTO, one can view the patent family for this specific application, including related applications filed at participating IP Offices[1].

Competitors and Litigation

  • Litigation History: The patent has been involved in several litigation cases, notably against Pentech Pharmaceuticals, which filed Abbreviated New Drug Applications (ANDAs) for generic versions of the patented drugs[2].
  • Expert Testimony: Experts in organic chemistry and drug formulation, such as Drs. Alexander Klibanov, Robert S. Langer, and Daniel G. Anderson, have been involved in these cases to testify about infringement and validity[2].

Search and Analysis Tools

Several tools and resources are available for searching and analyzing patents like 7,078,058.

USPTO Resources

  • Patent Public Search: This tool provides enhanced access to prior art and is useful for conducting comprehensive patent searches[1].
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques[1].

International Resources

  • European Patent Office (EPO): The esp@cenet database provides access to Europe's patent databases and includes machine translations for some languages[1].
  • World Intellectual Property Organization (WIPO): The PATENTSCOPE® Search Service offers full-text search of published international patent applications and machine translations for some documents[1].

Economic and Research Implications

The Patent Claims Research Dataset provided by the USPTO can offer insights into the scope and claims of patents like 7,078,058.

Patent Scope Measurements

  • The dataset includes detailed information on claims from U.S. patents and applications, which can be used to analyze the patent scope and dependency relationships between claims[3].

Conclusion

United States Patent 7,078,058 is a significant patent in the pharmaceutical industry, particularly for the treatment of scalp psoriasis. Understanding its scope, claims, and the broader patent landscape is essential for both legal and business strategies.

Key Takeaways

  • Patent Scope: The patent covers foamable pharmaceutical compositions containing steroids for treating scalp psoriasis.
  • Claims: The patent includes independent and dependent claims defining the composition and method of treatment.
  • Patent Landscape: The patent is part of a family of related patents and has been involved in litigation cases.
  • Search and Analysis Tools: Various tools like the USPTO's Patent Public Search and international databases are available for searching and analyzing patents.
  • Economic Implications: The Patent Claims Research Dataset provides valuable insights into patent scope and claims.

FAQs

Q: What is the main subject of United States Patent 7,078,058? A: The patent covers foamable pharmaceutical compositions containing steroids for treating scalp psoriasis.

Q: Who are the inventors and assignees of the patent? A: The patent was invented by several individuals and assigned to Connetics Corporation.

Q: What are the key components of the foamable pharmaceutical composition described in the patent? A: The composition includes a foamable base and a steroid as the active ingredient.

Q: Has the patent been involved in any litigation? A: Yes, the patent has been involved in several litigation cases, notably against Pentech Pharmaceuticals.

Q: What tools can be used to search and analyze patents like 7,078,058? A: Tools such as the USPTO's Patent Public Search, Global Dossier, and international databases like the EPO's esp@cenet and WIPO's PATENTSCOPE® Search Service can be used.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN .... Retrieved from https://www.govinfo.gov/content/pkg/USCOURTS-ilnd-1_08-cv-01083/pdf/USCOURTS-ilnd-1_08-cv-01083-0.pdf
  3. Patent Claims Research Dataset - USPTO. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,078,058

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,078,058

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9504265.1Mar 03, 1995

International Family Members for US Patent 7,078,058

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 253367 ⤷  Subscribe
Australia 4885196 ⤷  Subscribe
Australia 709320 ⤷  Subscribe
Brazil 9607687 ⤷  Subscribe
Canada 2214436 ⤷  Subscribe
China 1082817 ⤷  Subscribe
China 1179720 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.